UBS Maintains a Buy Rating on Micron Technology, Inc. (MU)
On January 7, 2026, TheFly reported that UBS maintained a Buy rating and boosted its price goal for Micron Technology, Inc. (NASDAQ:MU) from $300 to $400.
Insider Monkey Blog
CommScope Holding Company, Inc. (COMM)’s RUCKUS Networks Introduces AI and Wi-Fi 7 Innovations
CommScope Holding Company, Inc.
Piper Sandler Maintains an Overweight rating on Arrowhead Pharmaceuticals, Inc. (ARWR)
On December 17, 2025, TheFly reported that Piper Sandler maintained its Overweight rating for Arrowhead Pharmaceuticals, Inc.
Opendoor Technologies Inc. (OPEN) Acquires Homebuyer.com, Growth Chief Confirms
According to a post by Chief Growth Officer Morgan Brown, Opendoor Technologies Inc. (NASDAQ:OPEN) announced the acquisition of Homebuyer.com on December 24, 2025.
UBS Beleives Centrus Energy Corp. (LEU) Positioned for ‘Significant’ DOE Funding
On December 24, 2025, TheFly reported that UBS said Centrus Energy Corp.
Ondas Holdings Inc. (ONDS) Plans to Rename as Ondas Inc.
On January 02, 2026, The Fly reported that Ondas Holdings Inc. (NASDAQ:ONDS) has declared that it plans to rename itself as Ondas Inc.
Needham Analyst Keeps a Buy Rating on Praxis Precision Medicines, Inc. (PRAX)
On January 5, 2026, TheFly reported that Needham analyst Ami Fadia kept a Buy recommendation on Praxis Precision Medicines, Inc.
Why is Bloom Energy Corporation (BE) Stock Attracting Smart Money?
Forbes reported on January 5, 2026, that following market reactions to an existing $600 million credit line, Bloom Energy Corporation (NYSE:BE) shares rose 14%.
BofA Keeps Neutral Rating on Lumentum Holdings Inc. (LITE)
In mid-December, Wall Street firms raised their price targets for the company on multiple occasions.
Viasat, Inc. (VSAT) Unveils Ka-band Network
On December 15, 2025, TheFly reported that Viasat, Inc.
H.C. Wainwright is Bullish on Cogent Biosciences, Inc. (COGT)
Based on a research note dated January 6, 2026, The Fly reported that H.C. Wainwright reaffirmed a Buy rating and lifted its price target for Cogent Biosciences, Inc.
Aris Mining Corporation (ARMN) Successfully Acquires Remaining 49% Stake in the Soto Norte Venture
On December 12, 2025, Aris Mining Corporation (NYSE:ARMN) declared that it had successfully acquired the remaining 49% stake in the Soto Norte joint venture in Colombia from MDC...
Deutsche Bank Maintains a Buy Rating on EchoStar Corporation (SATS)
On December 19, 2025, TheFly reported that Deutsche Bank boosted its price objective for EchoStar Corporation (NASDAQ:SATS) to $131 from $97.
Goldman Sachs Retains a Neutral Rating on Planet Labs PBC (PL)
According to a research note dated December 17, 2025, TheFly reported that Goldman Sachs lifted its price target on Planet Labs PBC (NYSE:PL) from $10.90 to $12.30 and retained...
Why TMC the metals company Inc. (TMC) is One of the Best Performing Stocks of 2025?
On December 23, 2025, the NYTimes reported that the Trump administration announced that it had received an application for seabed mining exploration in international waters, marking...
ABIVAX Société Anonyme (ABVX) Rumored To Attract Interest From Eli Lilly
According to a story in the French-language newspaper La Tribune on December 24, 2025, there have been rumors that Eli Lilly has been drawing interest in the French biotechnology...
Citizens Maintains An Outperform Rating On Terns Pharmaceuticals, Inc. (TERN)
On December 11, 2025, TheFly reported that Citizens boosted its price goal for Terns Pharmaceuticals, Inc. (NASDAQ:TERN) to $57 from $35.
Wells Fargo Initiates Coverage On Celcuity Inc. (CELC)
On December 12, 2025, TheFly reported that Wells Fargo started covering Celcuity Inc. (NASDAQ:CELC) with a $126 price target and an Overweight rating.
Jim Cramer Commented on These 13 Stocks From Different Market Sectors
Jim Cramer, the host of Mad Money, spent Thursday explaining how each major market sector performed in 2025, and pointed out what worked, what lagged, and what that might signal...
Jim Cramer Discussed These 11 Stocks and Recent Market Rotation
Jim Cramer, the host of Mad Money, said on Thursday that the market is moving through a familiar rotation in which stocks that led gains previously are now being sold to raise...
12 Best Software Infrastructure Stocks to Buy According to Hedge Funds
An estimated $45 trillion opportunity may emerge in the software application layer as AI infrastructure spending moves up the stack, according to Byron Dieter, Partner at Bessemer...
Crypto vs Stocks: Which Is the Better Investment in 2026?
If you’re an investor, then you’re most likely asking yourself one question right now: “Should I invest my funds in crypto or stocks this year?” Cryptocurrency has recently...
Here’s What Analysts Think About Biogen Inc. (BIIB)
Biogen Inc. (NASDAQ:BIIB) is one of the best performing pharma stocks in 2025. Biogen Inc. (NASDAQ:BIIB) received several rating updates on January 8.
AbbVie Inc. (ABBV) Gets Downgraded to Peer Perform From Outperform by Wolfe Research
AbbVie Inc. (NYSE:ABBV) is one of the best performing pharma stocks in 2025. AbbVie Inc.
Berenberg Bank Remains Bullish on AstraZeneca PLC (AZN) – Here’s Why
AstraZeneca PLC (NASDAQ:AZN) is one of the best performing pharma stocks in 2025.
Eli Lilly and Company (LLY) to Acquire Ventyx Biosciences
Eli Lilly and Company (NYSE:LLY) is one of the best performing pharma stocks in 2025.
Jefferies Reaffirms a Buy Rating on GSK plc (GSK) – Here’s Why
GSK plc (NYSE:GSK) is one of the best performing pharma stocks in 2025. Jefferies reaffirmed a Buy rating on GSK plc (NYSE:GSK) on January 7 and set a price target of $55.60.
Amarin Corporation (AMRN) Announces Select Unaudited Financial Highlights
Amarin Corporation plc (NASDAQ:AMRN) is one of the best performing pharma stocks in 2025.
Truist Lifts PT on Teva Pharmaceutical Industries (TEVA) to $36 From $32
Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best performing pharma stocks in 2025.
Truist Raises PT on Amneal Pharmaceuticals (AMRX) to $15 From $14
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) is one of the best performing pharma stocks in 2025. On January 7, Truist raised the price target on Amneal Pharmaceuticals, Inc.
Indivior PLC (INDV) Announces Full-Year 2026 Financial Guidance
Indivior PLC (NASDAQ:INDV) is one of the best performing pharma stocks in 2025.
Amylyx Pharmaceuticals (AMLX) Announces the Selection of AMX0318 as Development Candidate for PBH and Other Rare Diseases
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) is one of the best performing pharma stocks in 2025. Amylyx Pharmaceuticals, Inc.
Jim Cramer on AeroVironment: “That’s a Terrific Company”
“But I got to tell you, you got a lucky break.
Jim Cramer on Procter & Gamble: “It Has the Opportunity to Shake Things Up”
The Procter & Gamble Company (NYSE:PG) is one of the stocks Jim Cramer talked about.
Jim Cramer on Microsoft: “Stock’s Been Punished By the Fact That Management Wants to Spend a Fortune on AI”
“How about Microsoft? Alright, this company’s been doing very well, but its stock’s been punished by the fact that management wants to spend a fortune on AI.
Jim Cramer Discusses CrowdStrike After Jensen Huang’s Endorsement
CrowdStrike Holdings, Inc. (NASDAQ:CRWD) is one of the stocks Jim Cramer talked about.
Jim Cramer on JPMorgan: “You Wait for the Reaction to Jamie’s Cautious Commentary to Give You a Better Entry Point”
JPMorgan Chase & Co. (NYSE:JPM) is one of the stocks Jim Cramer talked about.
Jim Cramer on Wingstop: “I Can’t Pound the Table When We Still Have Too High Food Inflation”
Wingstop Inc. (NASDAQ:WING) is one of the stocks Jim Cramer talked about.
Jim Cramer on Rambus: “It’s Not That Expensive Versus Growth”
Rambus Inc. (NASDAQ:RMBS) is one of the stocks Jim Cramer talked about.
Jim Cramer on Nebius: “The Opportunities Are Better Elsewhere”
Nebius Group N.V. (NASDAQ:NBIS) is one of the stocks Jim Cramer talked about.
Jim Cramer on Palo Alto: “I Think It Is a Buy”
“I think that Nikesh Arora does a great job. I slighted him too much. I said so many good things about CrowdStrike earlier.
Jim Cramer Says He “Wouldn’t Mind a Speculative Position Only on Roblox”
Roblox Corporation (NYSE:RBLX) is one of the stocks Jim Cramer talked about.
Jim Cramer Medline: “It’s a Terrific Company”
“But again, the fact that the IPO market was able to mostly self-correct in these situations and stamp out the froth, that’s what we really like, it’s a good thing for stocks...
Jim Cramer Says “Fermi’s More of a Business Plan Than a Business”
“Let’s not forget Fermi, which came public at the beginning of October on the heels of the most speculative AI-related trading of the year.
Jim Cramer Discusses CoreWeave’s IPO Surge and Pullback
“Now, you know what? I can say the same thing about one that I talked about a lot on the show, CoreWeave.
Jim Cramer on Circle Internet: “On Paper, This One’s a Standout”
“Alright, let’s start with Circle Internet Group. Let me explain how this works. This is a stablecoin issuer. On paper, this one’s a standout.
Jim Cramer on Celsius Holdings: “The Company’s Doing Quite Well”
Celsius Holdings, Inc. (NASDAQ:CELH) is one of the stocks Jim Cramer talked about.
Is BellRing Brands (BRBR) One of the Oversold Stocks to Buy Now?
BellRing Brands Inc. (NYSE:BRBR) is one of the oversold stocks to buy now.
Bernstein Gives Coinbase (COIN) an Outperform Rating Amid Tokenization Supercycle Outlook
Coinbase Global Inc. (NASDAQ:COIN) is one of the oversold stocks to buy now.
Raymond James Upgrades WaterBridge Infrastructure (WBI) to Strong Buy Following Midstream Sector Rating Adjustments
WaterBridge Infrastructure (NYSE:WBI) is one of the oversold stocks to buy now.
Hedge Fund Resource Center
